Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leith Soledad León-Maldonado1, Nancy López-Olmedo2, Raúl Murillo3

  • 1Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.. lmleiths@gmail.com.

Salud Publica De Mexico
|February 20, 2025
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trial.

Scientific reports·2026
Same author

Knowledge, attitudes, and practices related to adult vaccination among adults and healthcare professionals across Mexico.

PloS one·2026
Same author

Genotype distribution of human papillomavirus (HPV) types in oral gargle specimens among men living with HIV in Mexico, Brazil, and Puerto Rico: A cross-sectional study.

The Journal of infection·2026
Same author

Association of alcohol consumption with oral high-risk human papillomavirus infection: a cross-sectional study within the multinational HPV infection in men (HIM) cohort.

Lancet regional health. Americas·2026
Same author

Extended HPV typing as an efficient alternative within HPV-based screening programs.

International journal of cancer·2026
Same author

Association of Levonorgestrel-Containing Emergency Contraceptive Pills with Breast Cancer in Premenopausal Latin American Women: The PRECAMA Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Cervical cancer screening test usage, including Papanicolaou (Pap) tests and human papillomavirus (HPV) tests, declined during the COVID-19 pandemic but showed recovery by 2023. Higher socioeconomic status and urbanization correlated with increased screening rates.

Area of Science:

  • Gynecology
  • Public Health
  • Epidemiology

Context:

  • The COVID-19 pandemic significantly disrupted routine healthcare services globally.
  • Cervical cancer screening, utilizing Papanicolaou (Pap) tests and human papillomavirus (HPV) tests, is crucial for early detection and prevention.
  • Understanding screening trends pre- and post-pandemic is vital for public health strategies in Mexico.

Purpose:

  • To estimate the prevalence of Papanicolaou (Pap) and human papillomavirus (HPV) test usage before and after the SARS-CoV-2 pandemic.
  • To analyze changes in cervical cancer screening test utilization among women aged 25-64 in Mexico.
  • To identify socioeconomic and urbanization factors associated with screening test uptake.

Summary:

  • Pap test usage decreased from 34.6% in 2018 to 24.9% in 2021, recovering to 31.5% by 2023.

Related Experiment Videos

  • HPV test usage followed a similar trend, dropping from 12.7% in 2018 to 11% in 2021, then rising to 16.0% in 2023.
  • Higher socioeconomic status and urbanization were linked to increased use of cervical cancer screening tests.

    • Impact:

    • The findings highlight the pandemic's impact on essential cancer screening programs.
    • Results underscore the need for updated public health guidelines and revised strategies to improve cervical cancer screening and follow-up in Mexico.
    • Addressing disparities in screening access based on socioeconomic and urbanization factors is critical for effective cervical cancer prevention.